Intravitreal Injection Rates for Neovascular Age-Related Macular Degeneration in Australia During the 2020 COVID-19 Lockdowns
.
Source: Ophthalmic Epidemiology - Category: Opthalmology Authors: Sachin PhakeyAnthony J HallLyndell L Lima Centre for Eye Research Australia, The Royal Victorian Eye and Ear Hospital, Victoria, Australiab Ophthalmology, Alfred Health, Victoria, Australiac Department of Surgery, Monash University, Victoria, Australiad O Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Australia Health | COVID-19 | Epidemiology | Hospitals | Opthalmology